EGFR and cancer: Variant form of CD44 (CD44v) [12–17] and HER1 [18] associate with xCT in epithelial cancers or gliomas and stabilize xCT, respectively, resulting in the survival of CSCs in the oxidative stress by anti-cancer drugs.